mir microarray analysis (Yanaihara Institute Inc)
Structured Review
Mir Microarray Analysis, supplied by Yanaihara Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mirna+microarray+analysis/mirna+microarray+analysis/10__2147_slash_ott__s72457-28-206-196
Average 90 stars, based on 1 article reviews
Images
Related Articles
Microarray:Article Title: Genome-wide analysis of microRNA and mRNA expression signatures in cancer Article Snippet: .. Yanaihara et al 14 identified unique profiles of 43 miRNAs that could discriminate between lung cancer and noncancerous tissues by analyzing 104 pairs of primary lung cancers and noncancerous lung tissue by Article Title: Antitumor effects of hsa‑miR661‑3p on non‑small cell lung cancer in vivo and in vitro. Article Snippet: .. Yanaihara et al used a Article Title: Biomarkers and molecular testing for early detection, diagnosis, and therapeutic prediction of lung cancer. Article Snippet: Genomic, proteomic, and epigenomic biomarkers are being investigated for the early detection, diagnosis, and prediction of therapy response in lung cancer.. Biomarkers must be validated using one or more cohorts after discovery, ideally in blinded cohorts, and in well-controlled prospective trials.. Although there are many studies of lung cancer biomarkers, none except for prediction of response for certain targeted therapies have been validated for clinical use. Article Title: MicroRNA-198 inhibits proliferation and induces apoptosis of lung cancer cells via targeting FGFR1. Article Snippet: Lung cancer is the most common cause of death from cancer worldwide and recent studies have revealed that microRNAs play critical roles to regulate lung carcinogenesis.. Here we present evidence to show the role of miR‐198 in lung cancer development.. Our results showed that ectopic expression of miR‐198 inhibits the viability and induces the apoptosis of human non‐small cell lung cancer cells A549 and NCI‐H460, while miR‐198 inhibition resulted in opposite changes. Article Title: Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients Article Snippet: .. Notably, a previous study by Yanaihara et al. detected decreased miR-224 levels in human lung cancer tissues using Article Title: Non-coding RNAs in lung cancer Article Snippet: .. Yanaihara et al. in 2006 discriminated lung cancer tissues from adjacent noncancerous lung tissue using Article Title: miR-32 functions as a tumor suppressor and directly targets SOX9 in human non-small cell lung cancer Article Snippet: .. 70 o n 26 -O ct -2 01 8 F or p er so na l u se o nl y. Powered by TCPDF (www.tcpdf.org) 1 / 1 OncoTargets and Therapy 2015:8submit your manuscript | www.dovepress.com Dovepress Dovepress 1774 Zhu et al MicroRNAs (miRs) are a class of short (approximately 22 nucleotides in length), endogenous, single-stranded, nonprotein-coding RNAs that directly bind to the 3′ untranslated regions (3′ UTRs) of target messenger RNAs (mRNAs), leading to mRNA degradation or translational suppression.2 miRs are involved in many different biological processes, including cell growth, apoptosis, development, differentiation, and endocrine homeostasis.3 Accumulating studies also suggest that miRs play essential roles in the biology of human cancers, which may provide a new and promising way to treat cancer.4–6 The dysregulation of miR expression has frequently been reported and is closely associated with tumor initiation, promotion, and progression. miR-32 has been implicated in the pathogenesis of several human malignancies. miR-32 expression is upregulated in colorectal cancer,7 kidney cancer,8 prostate cancer,9 and multiple myeloma,10 and acts as a potential oncogene in these tumors; however, miR-32 expression is also significantly decreased in gastric cancer and osteosarcoma, and acts as a candidate tumor suppressor.11,12 Notably, Yanaihara et al revealed miR-32 downregulation in lung cancer by Expressing:Article Title: Antitumor effects of hsa‑miR661‑3p on non‑small cell lung cancer in vivo and in vitro. Article Snippet: .. Yanaihara et al used a Article Title: MicroRNA-198 inhibits proliferation and induces apoptosis of lung cancer cells via targeting FGFR1. Article Snippet: Lung cancer is the most common cause of death from cancer worldwide and recent studies have revealed that microRNAs play critical roles to regulate lung carcinogenesis.. Here we present evidence to show the role of miR‐198 in lung cancer development.. Our results showed that ectopic expression of miR‐198 inhibits the viability and induces the apoptosis of human non‐small cell lung cancer cells A549 and NCI‐H460, while miR‐198 inhibition resulted in opposite changes. Article Title: Non-coding RNAs in lung cancer Article Snippet: .. Yanaihara et al. in 2006 discriminated lung cancer tissues from adjacent noncancerous lung tissue using Article Title: miR-32 functions as a tumor suppressor and directly targets SOX9 in human non-small cell lung cancer Article Snippet: .. 70 o n 26 -O ct -2 01 8 F or p er so na l u se o nl y. Powered by TCPDF (www.tcpdf.org) 1 / 1 OncoTargets and Therapy 2015:8submit your manuscript | www.dovepress.com Dovepress Dovepress 1774 Zhu et al MicroRNAs (miRs) are a class of short (approximately 22 nucleotides in length), endogenous, single-stranded, nonprotein-coding RNAs that directly bind to the 3′ untranslated regions (3′ UTRs) of target messenger RNAs (mRNAs), leading to mRNA degradation or translational suppression.2 miRs are involved in many different biological processes, including cell growth, apoptosis, development, differentiation, and endocrine homeostasis.3 Accumulating studies also suggest that miRs play essential roles in the biology of human cancers, which may provide a new and promising way to treat cancer.4–6 The dysregulation of miR expression has frequently been reported and is closely associated with tumor initiation, promotion, and progression. miR-32 has been implicated in the pathogenesis of several human malignancies. miR-32 expression is upregulated in colorectal cancer,7 kidney cancer,8 prostate cancer,9 and multiple myeloma,10 and acts as a potential oncogene in these tumors; however, miR-32 expression is also significantly decreased in gastric cancer and osteosarcoma, and acts as a candidate tumor suppressor.11,12 Notably, Yanaihara et al revealed miR-32 downregulation in lung cancer by other:Article Title: Exosomes as Theranostics for Lung Cancer Article Snippet: miR-155, let-7a-2 , |


